Renovaro Inc (RENB)
1.49
+0.02
(+1.36%)
USD |
NASDAQ |
May 31, 16:00
1.46
-0.03
(-2.01%)
After-Hours: 20:00
Renovaro Free Cash Flow: -10.87M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -10.87M |
| December 31, 2023 | -11.54M |
| September 30, 2023 | -11.93M |
| June 30, 2023 | -11.80M |
| March 31, 2023 | -12.59M |
| December 31, 2022 | -12.06M |
| September 30, 2022 | -13.11M |
| June 30, 2022 | -15.74M |
| March 31, 2022 | -25.75M |
| December 31, 2021 | -25.30M |
| September 30, 2021 | -23.19M |
| June 30, 2021 | -20.66M |
| March 31, 2021 | -9.849M |
| December 31, 2020 | -11.40M |
| September 30, 2020 | -11.53M |
| June 30, 2020 | -10.64M |
| March 31, 2020 | -10.59M |
| December 31, 2019 | -9.541M |
| September 30, 2019 | -8.988M |
| June 30, 2019 | -9.224M |
| March 31, 2019 | -8.634M |
| December 31, 2018 | -7.565M |
| September 30, 2018 | -5.966M |
| June 30, 2018 | -4.368M |
| Date | Value |
|---|---|
| March 31, 2018 | -3.256M |
| December 31, 2017 | -1.521M |
| September 30, 2017 | -1.358M |
| June 30, 2017 | -1.178M |
| March 31, 2017 | -0.9888M |
| December 31, 2016 | -1.040M |
| September 30, 2016 | -1.383M |
| June 30, 2016 | -1.472M |
| March 31, 2016 | -3.206M |
| December 31, 2015 | -4.058M |
| September 30, 2015 | -3.852M |
| March 31, 2015 | -3.591M |
| December 31, 2014 | -2.034M |
| September 30, 2014 | -1.120M |
| June 30, 2014 | -0.6685M |
| March 31, 2014 | -0.4713M |
| December 31, 2013 | -0.036M |
| September 30, 2013 | -0.0288M |
| June 30, 2013 | -0.0261M |
| March 31, 2013 | -0.0301M |
| December 31, 2012 | -0.0325M |
| September 30, 2012 | -0.0339M |
| June 30, 2012 | -0.0317M |
| March 31, 2012 | -0.0249M |
Free Cash Flow Range, Past 5 Years
-25.75M
Minimum
Mar 2022
-8.988M
Maximum
Sep 2019
-13.82M
Average
-11.67M
Median
Free Cash Flow Benchmarks
| DIH Holding US Inc | -- |
| AIM ImmunoTech Inc | -23.04M |
| Perspective Therapeutics Inc | -23.28M |
| Protalix BioTherapeutics Inc | 4.369M |
| Armata Pharmaceuticals Inc | -46.82M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.634M |
| Cash from Investing (Quarterly) | -0.0916M |
| Cash from Financing (Quarterly) | 2.641M |
| Free Cash Flow Per Share (Quarterly) | -0.0246 |
| Free Cash Flow Yield | -9.85% |